High Risk Program

The Dubin Breast Center’s Cancer Risk Evaluation Program (CaRE) is dedicated to helping individuals who are at high risk for developing breast cancer. This risk may be attributed to a variety of factors including genetic mutation, or a personal or family history of cancer. Offering comprehensive services for risk assessment, cancer prevention, research, and education, our program helps people understand, reduce and manage their risk for developing breast cancer. 

Who Is Eligible? 

Individuals who are eligible for the CaRE program include those who have:

  • An inherited gene mutation (BRCA 1 or BRCA 2) or other syndrome
  • A personal or significant family history of premenopausal breast or ovarian or male breast cancer
  • A breast biopsy or surgery revealing lobular carcinoma in-situ (LCIS) or atypical hyperplasia (ADH, ALH)
  • A personal history of radiation therapy to the chest for lymphoma

Personalized, Multidisciplinary Care 

Individuals enrolled in the CaRE Program benefit by receiving accurate assessment of their individual risk for developing breast cancer along with comprehensive, personalized plans for reducing their breast cancer risk based on the most up-to-date information available. Patients also benefit by having the best chance for early cancer detection, when treatment is generally most effective. 

The CaRE Program is affiliated with The Tisch Cancer Institute at Mount Sinai, The Mount Sinai Hospital, and the Icahn School of Medicine. Located within one of the world’s premiere academic medical centers, we are able to provide our patients with access to the latest advances in care, including access to clinical research studies designed to develop novel preventive therapies for minimizing breast cancer risk. 

CaRE Program Services 

Among the outstanding services offered at the Dubin Breast Center’s CaRE Program are:

  • State-of-the-art breast cancer screening, including imaging with 3D mammography (a new, state-of-the-art form of mammography that allows for better screening and detection of breast cancers), ultrasound, and MRI
  • Expert pathology review by specialized breast pathologists for patients with previous biopsy or those requiring biopsy
  • Intensive follow-up with surveillance exams and coordination of imaging
  • Genetic counseling and testing by certified genetic counselors
  • Psycho-social counseling services and support programs to address the emotional needs of individuals living with breast cancer risk
  • Access to clinical research studies designed to develop novel prevention therapies for reducing breast cancer risk
  • Additional consultation with medical oncologists and plastic surgeons when indicated
  • Lifestyle counseling and referrals related to risk reduction, including diet, weight loss and exercise

Our Evaluation Process 

After careful consideration of the patient’s medical and family history, we create a personalized cancer risk profile to help guide each patient through the decision-making process regarding appropriate care.  All possible options for risk reduction are discussed. Potential pathways based on one’s personal risk level may include:  close surveillance with regular clinical evaluation and examination;  risk-reducing medications (chemoprevention); or preventive (prophylactic) surgery. Some individuals may be referred for genetic counseling and possible testing.

For More Information 

To speak to a specialist or to find out if you are eligible for the CaRE Program, please call 212-241-5928.


Contact Us

To call for an appointment or for more information: 
212-241-5928 
Mount Sinai Health System 
Klingenstein Pavilion 
1176 5th Avenue 
New York, New York